financetom
Business
financetom
/
Business
/
Jeff Bezos in space: Live-streaming starts 90 mins before take-off, check timings here
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jeff Bezos in space: Live-streaming starts 90 mins before take-off, check timings here
Jul 16, 2021 8:57 AM

Jeff Bezos is headed for infinity on July 20. The American billionaire and Amazon founder has chosen this particular date exactly 52 years after Apollo 11 astronauts Neil Armstrong and Buzz Aldrin landed on the moon. Bezos will be flying off in the reusable New Shepard rocket created by his company Blue Origin.

The entire journey will be live-streamed 90 minutes before the scheduled take-off and can be watched at www.blueorigin.com and https://www.youtube.com/channel/UCVxTHEKKLxNjGcvVaZindlg

As per Forbes, the scheduled lift-off in various time zones are:

13.00 Universal Time (UTC), which is:

6.00 am PST (Pacific Standard Time)

8.00 am CDT (Central Daylight Time)

9.00 am EST (Eastern Standard Time)

2.00 pm BST (British Summer Time)

6.30 pm IST (Indian Standard Time)

While we in India can see it live at 6.30 pm, Londoners can catch it at 2 pm and in Tokyo it will be 10 pm when Bezos and his team blast off. The Blue Origin flight will take off from a remote location in the west Texas desert. The location will not have an on-site public viewing area as per Forbes and the Texas Department of Transportation has planned to close a portion of State Highway 54.

Blue Origin till date has flown 15 successful unmanned missions to space and back above the Kármán Line and the 16th will be the first flight with a four-member crew. Jeff Bezos will be accompanied by three more people who will be a part of the New Shepherd crew, including his brother Mark Bezos, 82-year-old aeronautics pioneer Wally Funk and an 18-year-old space enthusiast Oliver Daemen.

If the 16th flight takes off as planned, Wally Funk will be the oldest person to ever travel to space while Oliver Daemen will be the youngest.

(Edited by : Shoma Bhattacharjee)

First Published:Jul 16, 2021 5:57 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Waterous Energy Fund Acquires Shares Of Greenfire Resources Ltd
BRIEF-Waterous Energy Fund Acquires Shares Of Greenfire Resources Ltd
Dec 24, 2024
Dec 24 (Reuters) - Greenfire Resources Ltd ( GFR ): * WATEROUS ENERGY FUND ACQUIRES SHARES OF GREENFIRE RESOURCES LTD. * WATEROUS ENERGY FUND MANAGEMENT: PURCHASED AGGREGATE OF 9.3 MILLION COMMON SHARES & 2.7 MILLION COMMON SHARE PURCHASE WARRANTS OF GREENFIRE RESOURCES * WATEROUS ENERGY FUND MANAGEMENT: PROPOSED DEAL FOR AGGREGATE PURCHASE PRICE OF US$81.9 MILLION Source text: Further company...
Terreno Realty Completes Redevelopment of California Land Parcel
Terreno Realty Completes Redevelopment of California Land Parcel
Dec 24, 2024
09:28 AM EST, 12/24/2024 (MT Newswires) -- Terreno Realty ( TRNO ) said Tuesday that it has completed the redevelopment of a 2.8-acre land parcel in Rancho Dominguez, California and leased all of the property on a short-term basis. The company said the property has been leased to a trucking and transloading provider for 18 months, and that the stabilized...
China's WuXi to sell Advanced Therapies unit amid US restrictions
China's WuXi to sell Advanced Therapies unit amid US restrictions
Dec 24, 2024
Dec 24 (Reuters) - China's WuXi AppTec said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, for an undisclosed sum. The company, along with other Chinese firms, have been at the center of new U.S. laws aimed at restricting...
Retail investors buy Novo dip after disappointing weight-loss drug data
Retail investors buy Novo dip after disappointing weight-loss drug data
Dec 24, 2024
By Bhanvi Satija Dec 24 (Reuters) - U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research. Daily net flows climbed to $15.6 million from $0.49 million a day earlier, after eagerly anticipated data showed Novo's experimental drug, CagriSema, helped patients...
Copyright 2023-2026 - www.financetom.com All Rights Reserved